Dr. Allan M. Green, M.D., Ph.D., J.D., serves as Co-Managing Director of SDG, LLC. Dr. Green has been Of Counsel to the law firm of Greenberg Traurig LLP since 2002 and is an Advisor of Obecure Ltd. He is a Principal in Ground Fluor Pharmaceuticals, Inc., and Co-Managing Director of SDG, LLC, in Cambridge, Massachusetts, a consulting organization supporting the U.S. Food and Drug Administration ( FDA )-regulated industry. Through his position at SDG, LLC, since 2011, he has advised it regarding FDA regulatory requirements for two of its products. He has been actively involved in several start-up ventures in the pharmaceutical industry. His legal practice focuses on the needs of the FDA-regulated industry. He serves as external counsel to a number of nonprofit foundations and hospitals involved in medical research. He is Adjunct Professor of Law and teaches Food and Drug Law at Boston College Law School. He co-founded Immune Control Inc. in 2001. He is a physician, lawyer and research scientist with experience as an Operating Officer in the pharmaceutical industry. He has 30 years' experience developing new drug products and specific experience in the development of new anti-retroviral drugs to the Board. Additionally, he has his FDA knowledge on the regulation of new drug products. He served as the Chief Technology Officer of North American Scientific Inc., since April 2002. Prior thereto, he served as the President of Theseus Imaging Corporation. He served as President of Neuroptix, Inc. From 1991 to 2002, he served as Vice President of Pharmaceutical and Biomedical Products for ML Strategies Inc., and Of Counsel to the law firm of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C. He served as the President of the Biotechnology Data Group in Cambridge, Massachusetts from 1986 to 1990, and as a consultant to many major pharmaceutical companies and investors in the pharmaceutical industry. Dr. Green served as Medical Director of New England Nuclear/DuPont Medical Products from 1975 to 1981 and was Chief of Nuclear Medicine, University Hospitals, Boston, from 1983 to 1986. He was an Instructor at Harvard Medical School and on the medical staffs of Massachusetts General Hospital and Boston Medical Center.
Dr. Green is the author of many scientific papers in biochemistry and drug development. He has been a practicing physician and is board certified in internal medicine and nuclear medicine. Dr. Green received his B.S. in economics in 1966 and his Ph.D. in biochemistry and metabolism in 1971, both from the Massachusetts Institute of Technology. He received his M.D. from Case Western Reserve University School of Medicine in 1972 and holds Board certification in both Internal Medicine and in Nuclear Medicine. He received his J.D. from Boston College Law School in 1991.
